EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Screening and Mechanistic Investigation of Synergistic Xanthine Oxidase Inhibitors Based on Structure–Activity Relationships

Zihan Qu, Xue Zhang, Yuxin Cui, Mengxin Yu, Li Li

Molecules · 16.07.2026 · 31 (14) · 2485

DOI: 10.3390/molecules31142485 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 16.07.2026. Verfasst von Zihan Qu und 4 weiteren Autor:innen. Beteiligte Einrichtung: The College of Chemistry, Changchun Normal University, Changchun 130032, China. Hauptthemen laut MEDLINE: Xanthine Oxidase, Enzyme Inhibitors, Flavonoids. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Provincial Natural Science Foundation, Changchun Normal University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In order to screen the synergistic inhibitors of xanthine oxidase (XOD), the inhibitory activities of 16 flavonoids in Coreopsis tinctoria were evaluated by structure–activity relationship in this study. Eight flavonoids were screened and were observed to have XOD inhibition and antioxidant capacity, and the zero-interaction potential (ZIP) score was used to determine the synergistic effect with allopurinol. Among them, butein and coreopsin showed good synergistic activity (average ZIP > 15). Subsequently, the inhibitory mechanism of butein and coreopsin alone and in combination with allopurinol on XOD was investigated using in vitro experiments. The inhibitory ability of both on XOD was relatively strong. After combination with two chalcones, the enzyme-inhibition effect of allopurinol was significantly improved. Butein and coreopsin can enhance the binding ability of allopurinol to XOD, induce the conformational change of the enzyme, and achieve synergistic inhibition. The binding mode and key amino-acid binding contribution of the complex were analyzed by computer simulation. In summary, the two chalcones might serve as potential XOD inhibitors and synergistic adjuvants for allopurinol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Xanthine OxidaseEnzyme InhibitorsFlavonoidsStructure-Activity RelationshipChalconesAllopurinolMolecular Docking SimulationDrug SynergismAntioxidants

Stichwörter der Autor:innen

allopurinolbuteincoreopsinstructure–activity relationshipsynergistic inhibitionxanthine oxidase

Substanzen

Xanthine OxidaseEnzyme InhibitorsFlavonoidsChalconesAllopurinolbuteinAntioxidants

Autor:innen und Institutionen

  • The College of Chemistry, Changchun Normal University, Changchun 130032, China.

Förderung

  • Jilin Provincial Natural Science Foundation
  • Changchun Normal University

Zitieren

APA

Qu, Z., Zhang, X., Cui, Y., Yu, M., & Li, L. (2026). Screening and Mechanistic Investigation of Synergistic Xanthine Oxidase Inhibitors Based on Structure–Activity Relationships. Molecules, 31(14), 2485. https://doi.org/10.3390/molecules31142485

Vancouver

Qu Z, Zhang X, Cui Y, Yu M, Li L. Screening and Mechanistic Investigation of Synergistic Xanthine Oxidase Inhibitors Based on Structure–Activity Relationships. Molecules. 2026;31(14):2485. doi:10.3390/molecules31142485

BibTeX
@article{Qu2026,
  author = {Qu, Zihan and Zhang, Xue and Cui, Yuxin and Yu, Mengxin and Li, Li},
  title = {Screening and Mechanistic Investigation of Synergistic Xanthine Oxidase Inhibitors Based on Structure–Activity Relationships},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {14},
  pages = {2485},
  doi = {10.3390/molecules31142485}
}
Kostenlos starten →